📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis. (2013)

First Author: Aiuti A

Attributed to: MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/humc.2013.119

PubMed Identifier: 23862696

Publication URI: http://europepmc.org/abstract/MED/23862696

Type: Journal Article/Review

Volume: 24

Parent Publication: Human gene therapy. Clinical development

Issue: 2

ISSN: 2324-8637